Market Overview

The AI-based Drug Repurposing Market is emerging as one of the fastest-growing segments within the pharmaceutical and artificial intelligence industries, driven by the need to accelerate drug discovery while reducing development costs and timelines. AI-powered drug repurposing leverages machine learning, deep learning, natural language processing (NLP), and predictive analytics to identify new therapeutic applications for existing drugs. This approach significantly lowers clinical development risks, shortens regulatory pathways, and improves success rates compared to traditional drug discovery methods.

According to MarketGenics, the global AI-based Drug Repurposing Market is projected to grow from USD 0.3 Billion in 2025 to USD 2.2 Billion by 2035, registering a CAGR of 23.1% during the forecast period. Increasing investments in AI-driven pharmaceutical research, precision medicine, rare disease therapeutics, and oncology drug development are expected to drive strong market expansion. The growing adoption of cloud computing, real-world evidence (RWE), genomic analytics, and AI-powered molecular modeling is further transforming the drug repurposing landscape.

To obtain a free sample research report - https://marketgenics.co/download-report-sample/ai-based-drug-repurposing-market-55315?utm_source=Free&utm_medium=ruchika

Market Growth Drivers

• Rising demand for faster and cost-effective drug discovery processes.
• Growing adoption of Artificial Intelligence (AI) and Machine Learning (ML) in pharmaceutical R&D.
• Increasing focus on drug repurposing for oncology, rare diseases, neurological disorders, and infectious diseases.
• Rising availability of genomic, proteomic, and clinical datasets for AI analysis.
• Growing investments in precision medicine and personalized therapeutics.
• Expansion of cloud computing, high-performance computing, and AI-based bioinformatics platforms.
• Increasing collaborations between pharmaceutical companies, biotechnology firms, research institutes, and AI technology providers.
• Government support for AI innovation and accelerated drug development programs.

Key Players

• Insilico Medicine
• BenevolentAI
• Exscientia plc
• Recursion Pharmaceuticals
• Atomwise Inc.
• Verge Genomics
• Healx
• BioXcel Therapeutics
• Schrödinger, Inc.
• XtalPi
• Iktos
• Valo Health
• Lantern Pharma
• Evotec SE
• Certara, Inc.
• NVIDIA Corporation
• Google DeepMind
• Microsoft Corporation
• IBM
• Amazon Web Services (AWS)

Regional Insights

North America

North America dominates the AI-based Drug Repurposing Market due to strong pharmaceutical R&D investments, widespread AI adoption, advanced healthcare infrastructure, and a robust biotechnology ecosystem. The United States remains the leading market supported by increasing collaborations between AI companies and pharmaceutical organizations.

Europe

Europe continues to witness significant growth driven by expanding AI research, government funding for life sciences innovation, increasing adoption of precision medicine, and strong biotechnology clusters across Germany, the United Kingdom, Switzerland, and France.

Asia-Pacific

Asia-Pacific is expected to register the fastest CAGR during the forecast period. Countries including China, India, Japan, South Korea, Singapore, and Australia are investing heavily in AI-driven drug discovery, genomics research, biotechnology innovation, and digital healthcare infrastructure.

Latin America

Brazil and Mexico are gradually adopting AI-enabled pharmaceutical research as biotechnology investments and healthcare digitalization continue to expand.

Middle East & Africa

The UAE and Saudi Arabia are investing in artificial intelligence, biotechnology, and healthcare innovation, creating new opportunities for AI-based drug discovery and repurposing platforms.

Future Outlook

The AI-based Drug Repurposing Market is expected to revolutionize pharmaceutical research by enabling faster identification of novel therapeutic indications for approved and investigational drugs. Future developments in generative AI, multimodal machine learning, digital twins, quantum computing, real-world evidence analytics, and multi-omics data integration will further enhance drug repurposing accuracy and efficiency. Growing demand for precision medicine, orphan drug development, pandemic preparedness, and AI-powered clinical decision support will continue to drive long-term market growth through 2035.

Related Reports:

Virtual Health Assistants Market

Smart Prosthetics Market

AI-powered EHR Systems Market

Digital Rehabilitation Market

Connected Ambulance Systems Market

Contact:
Mr. Debashish Roy
MarketGenics Global Research

800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States

USA: +1 (302) 303-2617
Email: sales@marketgenics.co
Website: https://marketgenics.co